Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
abbvie
abeona therapeutics
accent therapeutics
achilles therapeutics
acorda therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
ampyra
apokyn
apomorphine
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
biotech
biotech ipos
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cell therapy
cidara therapeutics
cigna
concert pharmaceuticals
What
drug
new
2
×
patients
2
×
acorda
advantages
approved
bar
bio
brings
cope
disease
episodes
expect
fda
friday
gamble
gets
help
late
looms
market
meant
medco’s
medications
mover
nod
parkinson’s
payers
physicians
plan
pricing
rival
roundup
sets
stop
treatment
type
ubiome
undone
vertex’s
Language
unset
Current search:
patients
×
" boston blog main "
×
new
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms